# Cannabis Use Patterns Among Adults Living With Chronic Pain Before and During the COVID Pandemic: Insights From the COVID-19 Cannabis Health Study

**Authors:** Amrit Baral, Denise C. Vidot, Bria-Necole A. Diggs, Isabella Jimenez, Varan Govind, Eva Widerstrom-Noga, Michelle Weiner, Johis Ortega, Marvin Reid, Jacqueline Sagen

PMC · DOI: 10.1155/prm/9631487 · 2025-10-23

## TL;DR

This study explores how cannabis use for chronic pain changed before and during the pandemic, focusing on factors like age and ethnicity.

## Contribution

The study reveals how the pandemic altered cannabis consumption methods and identifies sociodemographic factors linked to chronic pain-related cannabis use.

## Key findings

- Participants using cannabis for chronic pain were more likely to use a CBD/THC ratio.
- Smoking decreased while edibles and tinctures increased during the pandemic.
- Younger and Hispanic/Latino individuals had higher odds of using cannabis for chronic pain.

## Abstract

This study aims to identify sociodemographic factors associated with cannabis use for chronic pain management before and after COVID-19 was declared a pandemic. Furthermore, it seeks to compare cannabis use patterns in adults with and without chronic pain.

We analyzed US-based responses from the COVID-19 Cannabis Health Study, a cross-sectional online survey administered via REDCap between March 2020 and March 2022. All respondents were cannabis consumers in the past year. Cannabis use patterns and chronic pain were self-reported via the COVID-19 Cannabis Health Questionnaire. Statistical analysis included Chi-square tests, Fisher's exact tests, t-tests, and multivariable logistic regression with a two-tailed alpha of 0.05 for significance.

Among 2243 participants, 50.3% consumed cannabis to manage chronic pain. Younger age (< 40 years; aOR: 3.20, 95% CI: 2.59–3.96), Hispanic/Latino ethnicity (aOR: 2.20, 95% CI: 1.56–3.05), and higher income levels (> $100,000 annually; aOR: 1.69, 95% CI: 1.25–2.29) were associated with higher odds of consuming cannabis to manage chronic pain. Participants using cannabis for chronic pain were more likely to use a CBD/THC ratio. The pandemic led to increased dosages and changes in consumption methods: 40.5% increased their cannabis dose, smoking as the primary method declined from 62.2% before the pandemic to 34.5% afterward, while edibles rose from 7.9% to 30.9%, and tinctures from 3.2% to 8.6%. Route changes varied with chronic pain status.

There was a shift from smoking to nonsmoking methods to manage chronic pain. Those who were younger and those of Hispanic/Latino ethnicity had higher odds of using cannabis for chronic pain.

## Full-text entities

- **Diseases:** COVID (MESH:D000086382), Chronic Pain (MESH:D059350)
- **Chemicals:** CBD (-), THC (MESH:D013759)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12575038/full.md

---
Source: https://tomesphere.com/paper/PMC12575038